Compare Moderna, Inc. (MRNA) vs Nucor Corporation (NUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Nucor Corporation — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Nucor Corporation trades at $230.8 (market cap $52.55B). The key difference: Nucor Corporation is far larger — about 2.2× Moderna, Inc.'s market cap, and Nucor Corporation pays a 0.97% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | NUE | |
|---|---|---|
Market Cap | $23.60B | $52.55B |
Sector | Health | Basic Materials |
52-Week High | $81.80 | $266.35 |
52-Week Low | $22.36 | $131.78 |
Enterprise Value | $19.70B | $57.19B |
Dividend Yield | — | 0.97% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →
